*Administration via central line is recommended. If peripheral administration of GIAPREZA is needed, historically, the doses of angiotensin II given via a peripheral line were ≤10 ng/kg/min,d as a low concentration of 1 mL angiotensin II diluted in 1000 mL normal saline (0.9% sodium chloride [NS]). GIAPREZA should NOT be administered in the same peripheral line as other vasopressors. Blood pressure should be closely monitored.
aHospitals not reimbursed under the IPPS, including but not limited to critical access hospitals, excluded cancer hospitals, long-term acute care hospitals, Veterans Affairs hospitals, Department of Defense facilities, and hospitals in the state of Maryland, are not eligible to receive add-on payments.
bThis information is subject to change, and providers should consult relevant references for the description of each code to determine its appropriateness.
cThis list is not designed to be a comprehensive list of procedure codes for any given case. Other procedure codes may be appropriate and submitted to payers. Providers are solely responsible for determining the appropriate codes in billing payers. It is the provider’s responsibility to determine and submit appropriate codes, charges, and modifiers for the products and services rendered. Before filing any claim, providers should verify these requirements in writing with specific payers.
dData on file.